1.51
price down icon0.66%   -0.01
after-market Dopo l'orario di chiusura: 1.50 -0.01 -0.66%
loading
Precedente Chiudi:
$1.52
Aprire:
$1.49
Volume 24 ore:
56,587
Relative Volume:
0.31
Capitalizzazione di mercato:
$9.21M
Reddito:
$743.00K
Utile/perdita netta:
$-7.63M
Rapporto P/E:
-0.5033
EPS:
-3
Flusso di cassa netto:
-
1 W Prestazione:
-1.95%
1M Prestazione:
-12.21%
6M Prestazione:
-22.37%
1 anno Prestazione:
-34.06%
Intervallo 1D:
Value
$1.455
$1.5301
Intervallo di 1 settimana:
Value
$1.38
$1.56
Portata 52W:
Value
$1.29
$4.69

Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile

Name
Nome
Can-Fite Biopharma Ltd ADR
Name
Telefono
972 3 924 1114
Name
Indirizzo
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
Name
Dipendente
7
Name
Cinguettio
@CanFitePharma
Name
Prossima data di guadagno
2024-12-31
Name
Ultimi documenti SEC
Name
CANF's Discussions on Twitter

Confronta CANF con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CANF
Can-Fite Biopharma Ltd ADR
1.51 9.21M 743.00K -7.63M 0 -3.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2017-08-11 Iniziato Maxim Group Buy
2016-10-19 Ripresa ROTH Capital Buy
2016-08-29 Ripresa Rodman & Renshaw Buy
2015-11-30 Reiterato H.C. Wainwright Buy
2015-03-31 Reiterato H.C. Wainwright Buy
2015-03-30 Downgrade ROTH Capital Buy → Neutral
2014-12-29 Reiterato ROTH Capital Buy
2014-11-18 Iniziato H.C. Wainwright Buy
Mostra tutto

Can-Fite Biopharma Ltd ADR Borsa (CANF) Ultime notizie

pulisher
Mar 03, 2025

Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits - GlobeNewswire Inc.

Mar 03, 2025
pulisher
Jan 14, 2025

USC Law Launches New Online Certificate in Dispute Resolution - Business Wire

Jan 14, 2025
pulisher
Jan 10, 2025

Lenovo Integrates AI and Robotics to Deliver Smarter Retail Solutions - Business Wire

Jan 10, 2025
pulisher
Dec 07, 2024

Cronos Group Inc (NASDAQ: CRON) Could Slash -12.75% Soon - Stocks Register

Dec 07, 2024
pulisher
Dec 07, 2024

Commercial Metals Co (NYSE: CMC) Could Slash -1.03% Soon - Stocks Register

Dec 07, 2024
pulisher
Dec 05, 2024

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Reckitt Benckiser Group PLC (OTC: RBGLY) - Business Wire

Dec 05, 2024
pulisher
Dec 04, 2024

Can Fite Biopharma stock hits 52-week low at $1.86 - Investing.com India

Dec 04, 2024
pulisher
Nov 04, 2024

Can-Fite secures Australian patent for obesity treatment - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of WeRide Inc. - Business Wire

Oct 28, 2024
pulisher
Oct 18, 2024

Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com India

Oct 18, 2024
pulisher
Sep 25, 2024

Ratios in Focus: Analyzing Can-Fite Biopharma Ltd ADR (CANF)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 25, 2024
pulisher
Sep 02, 2024

Analytical Lens: Exploring Can-Fite Biopharma Ltd ADR (CANF)’s Financial Story Through Ratios - The Dwinnex

Sep 02, 2024
pulisher
Aug 26, 2024

List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel

Aug 26, 2024
pulisher
Aug 22, 2024

Wearable Devices Ltd. sets annual meeting for September 26 - Investing.com

Aug 22, 2024
pulisher
May 23, 2024

Martingale Risk – Philips Shareholders Group Action to be Filed in the Netherlands - Business Wire

May 23, 2024
pulisher
Nov 21, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 21, 2023
pulisher
Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire UK

Jul 12, 2023
pulisher
Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022
pulisher
May 27, 2022

bioAffinity Technologies Inc Stock Price Today | NASDAQ: BIAF Live - Investing.com

May 27, 2022
pulisher
Feb 01, 2022

NOVONIX to Commence Trading on Nasdaq through Level II ADR Program - Business Wire

Feb 01, 2022
pulisher
Mar 16, 2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma - Business Wire

Mar 16, 2021
pulisher
Oct 14, 2020

4 Penny Stocks On Robinhood To Buy Under $4 Now; Worth The Risk? - Penny Stocks

Oct 14, 2020
pulisher
Sep 16, 2020

Can-Fite BioPharma (CANF) Stock Price, News & Analysis - MarketBeat

Sep 16, 2020
pulisher
Jul 15, 2020

New Lenovo Research: People are Working More by Not Going to Work, but Worry about Home Tech, Data Security and Personal Costs - Business Wire

Jul 15, 2020
pulisher
Feb 19, 2020

Global Metal Casting Market 2020-2024 | Evolving Opportunities with Acast and Alcast Co. | Technavio - Business Wire

Feb 19, 2020
pulisher
Aug 24, 2019

10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance

Aug 24, 2019
pulisher
Aug 02, 2016

Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha

Aug 02, 2016
pulisher
Sep 03, 2015

letgo Raises $100 Million in Series A Funding from Naspers - Business Wire

Sep 03, 2015
pulisher
Mar 20, 2014

Ipsen Announces That Its Controlling Shareholder, Mayroy, Sold Approximately 7% of Ipsen’s Share Capital via Private Placement - Business Wire

Mar 20, 2014
pulisher
Oct 04, 2012

Can-Fite BioPharma Begins Trading in U.S. through Launch of ADRs - CNBC

Oct 04, 2012

Can-Fite Biopharma Ltd ADR Azioni (CANF) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):